1[1]Penagini R,Schoeman MN,Dent J,et al.Motor events underlying gastro-esophageal reflux in ambulant patients with reflux esophagitis.Neurogastroentorol Motil,1996;8(2):131-41
2[2]Grossi L,Ciccaglione AF,Travaglini N,et al.Swallows,esophageal and gastric motility in normal subjects and in patients with gastro-oesophageal reflux disease:a 24h PH-manometric study.Neuro-gastroenterol Motil,1998;10(2):115-21
3[3]Johnson LF,Harmon JW.Experimental esophagitis in a rabbit model.J Clin Gastroenterol 1986;8(Suppl 1):26-44
4[4]Bremner RM,Crookes PF,DeMeester TR,et al.Concentration and refluxed acid and esophageal mucosal injury.Am J Surg,1992;164(5):522-7
5[5]Blackshaw LA,Dent J.Lower esophageal sphincter response to noxious esophageal chemical stimuli in the ferret:involvement of tachykinin receptors.J Auton Nerv Syst,1997;13:66(3):189-200
6[6]Eriksen CA,Cullen PT,Sutton D,et al.Abnormal esophageal transit in patients with typical reflux symptoms but normal endoscopic and PH profiles.Am J Surg,1991,161(6):657-61
7[7]Chiba N,DeGara CJ,Wilkinson JM,et al.Speed of healing and symptom relief in grade Ⅱ to Ⅳ gastroesophageal reflux disease:a metaanalysis.Gastroenterology,1997,112(6):1798-810
8[8]Peters FTM,Ganesh S,Kuipers EJ,et al.Endoscopic regression of Barrett's esophagus during omeprazole treatment:a randomised double blind study.Gut,1999,45(4):489-94
9Pohland GJ, ,Scaveiehy SA, Lasky SS, et al. Lansopraxole overutylixation: methods for step-down therapy. Am J Manag Care, 2005,9(5) :353-358.
10Ruth M, Hamefin B, Rohss K,et al. The effeet of mosapride, a novel prokinetie,on acid reflux variables in patients with gastrooesophageal reflux disease. Aliment Pharmacol Ther, 1998, 12 (1) :35-40.
